Issues in the use of inhaled glucocorticoids

被引：159

作者：

Kamada, AK ^{[1
]}

Szefler, SJ ^{[1
]}

Martin, RJ ^{[1
]}

Boushey, HA ^{[1
]}

Chinchilli, VM ^{[1
]}

Drazen, JM ^{[1
]}

Fish, JE ^{[1
]}

Israel, E ^{[1
]}

Lazarus, SC ^{[1
]}

Lemanske, RF ^{[1
]}

Cherniak, RM ^{[1
]}

Hurd, SS ^{[1
]}

Peters, SP ^{[1
]}

Sorkness, C ^{[1
]}

Szefler, SJ ^{[1
]}

Zwillich, CW ^{[1
]}

机构：

[1] NATL JEWISH CTR IMMUNOL & RESP MED, DEPT MED, DENVER, CO 80206 USA

来源：

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 1996年 / 153卷 / 06期

关键词：

D O I：

10.1164/ajrccm.153.6.8665030

中图分类号：

R4 [临床医学];

学科分类号：

1002 ; 100602 ;

摘要：

Asthma is now regarded as an inflammatory disease, and inhaled glucocorticoids (iGCs) are recommended earlier in the course of treatment of patients with this disorder. Although iGCs are highly efficacious in treating asthma, many questions about this treatment modality remain unanswered. The purpose of this review is to define those areas where data are controversial or limited and where further research is needed regarding this important mode of treatment.

引用

页码：1739 / 1748

页数：10

共 85 条

[41] BONE METABOLISM IN CHILDREN WITH ASTHMA TREATED WITH INHALED BECLOMETHASONE DIPROPIONATE [J].

KONIG, P ;

HILLMAN, L ;

CERVANTES, C ;

LEVINE, C ;

MALONEY, C ;

DOUGLASS, B ;

JOHNSON, L ;

ALLEN, S .

JOURNAL OF PEDIATRICS, 1993, 122 (02) :219-226

[42]

Langdon C. G., 1994, European Respiratory Journal, V7, p366S

[43]

LANGDON CG, 1992, EUROPEAN RESPIRA S15, V5, P368

[44] A COMPARISON OF FLUTICASONE PROPIONATE 200-MU-G/DAY WITH BECLOMETHASONE DIPROPIONATE 400-MU-G/DAY IN ADULT ASTHMA [J].

LEBLANC, P ;

MINK, S ;

KEISTINEN, T ;

SAARELAINEN, PA ;

RINGDAL, N ;

PAYNE, SL .

ALLERGY, 1994, 49 (05) :380-385

[45] EFFECTS OF SHORT-TERM INHALED BUDESONIDE AND BECLOMETHASONE DIPROPIONATE ON SERUM OSTEOCALCIN IN PREMENOPAUSAL WOMEN [J].

LEECH, JA ;

HODDER, RV ;

OOI, DS ;

GAY, J .

AMERICAN REVIEW OF RESPIRATORY DISEASE, 1993, 148 (01) :113-115

[46]

LEMANSKE RF, 1993, ALLERGY PRINCIPLES P, P1

[47] NEW PERSPECTIVES ON INHALED DRUG-DELIVERY AND SYSTEMIC BIOACTIVITY [J].

LIPWORTH, BJ .

THORAX, 1995, 50 (02) :105-110

[48]

LITTLEWOOD JM, 1988, LANCET, V1, P115

[49]

Lorentzen K. A., 1994, European Respiratory Journal, V7, p366S

[50] EVALUATION OF FLUTICASONE PROPIONATE (500 MU-G DAY(-1)) ADMINISTERED EITHER AS DRY POWDER VIA A DISKHALER(R) INHALER OR PRESSURIZED INHALER AND COMPARED WITH BECLOMETHASONE DIPROPIONATE (1000 MU-G DAY(-1)) ADMINISTERED BY PRESSURIZED INHALER [J].

LUNDBACK, B ;

ALEXANDER, M ;

DAY, J ;

HEBERT, J ;

HOLZER, R ;

VANUFFELEN, R ;

KESTEN, S ;

JONES, AL .

RESPIRATORY MEDICINE, 1993, 87 (08) :609-620

← 1 2 3 4 5 6 7 8 9 →